Asia Pacific Medical Devices Market Size, Share & Analysis, By Type (Orthopedic Devices, Cardiovascular Devices, Diagnostic Imaging, In-vitro Diagnostics, Minimally Invasive Surgery (MIS), Wound Management, Diabetes Care, Ophthalmic, Dental, Nephrology, General Surgery, and Others), By End User (Hospitals & ASCs, Clinics, and Others), and Regional Forecast, 2025-2032

The Asia Pacific medical devices market size was valued at USD 133.57 billion in 2024. The market is projected to grow from USD 143.12 billion in 2025 to USD 244.77 billion by 2032, exhibiting a CAGR of 8.0% during the forecast period.

The medical devices industry encompasses a wide range of products, from simple products such as syringes and tongue depressors to more complex products such as echocardiography devices. The growth of the Asia Pacific market for medical devices is attributed to the growing burden of chronic disorders and an aging population, fueling the demand for effective diagnosis and surgery options.

• For instance, as per the data published by Elsevier B.V. in February 2023, chronic diseases affected around 81.1% of the adult population in China. Moreover, the prevalence of chronic conditions increased among the age group of 80-84 years old.

Furthermore, the major players in the market, such as Nipro Corporation, Shimadzu Corporation, and Shenzhen Mindray Bio-Medical Electronics Co., Ltd, have been focusing on expanding their product offerings.

• In April 2023, Nipro Europe Group Companies announced its partnership with Diaverum, intending to expand its product offerings in the medical devices portfolio.

Market Dynamics

Market Drivers

Growing Burden of Chronic Diseases and Increasing Focus of Market Players in New Product Launches Fueling Market Growth

The burden of chronic diseases such as cancer, cardiac arrest, HIV, Alzheimer’s, and genetic disorders, has been growing significantly throughout the Asia Pacific region.

• For instance, as per the data published by BioMed Central Ltd in 2021, by 2035, the prevalence of dementia in Japan is expected to be between 20-25%. Moreover, this prevalence is expected to reach 30% by 2045.
• Similarly, as per the data published by the World Health Organization (WHO) in 2022, the prevalence of cancer in the past five years in China was around 10,968,974, and the number of new cases in 2022 was around 4,824,703.

Such a high burden of chronic diseases in the Asia Pacific region has been fueling the demand for advanced diagnostics and treatment devices for on-time and effective treatment of the disease.

Furthermore, market players have been focusing on the launch of effective diagnostic and devices for treatment to fulfill the growing demand.

• For instance, in May 2025, iRhythm Technologies, Inc. announced the launch of the Zio long-term continuous ECG monitoring (LTCM) system in Japan.
• In March 2025, MicroPort Scientific Corporation announced the National Medical Products Administration (NMPA) approval of the Toumai SP Laparoscopic Surgical Robot for its commercialization in China.

Therefore, the growing burden of chronic diseases and the increasing focus of the market players on new product launches have been fueling the Asia Pacific medical devices market growth.

Market Restraints

Limited Healthcare Budget in Developing Nations to Put Reimbursement Pressure Limiting Market Growth

Asia Pacific comprises developing and developed nations such as China, India, Indonesia, Malaysia, Australia, Hong Kong, Japan, and New Zealand. Many countries have regulatory scenarios and reimbursement policies for medical devices.

• For instance, according to an article published by Qualtech, a medical device regulatory CRO, the reimbursement system in China has become quite complex compared to the past, as a majority of the devices are being reimbursed as a part of a medical procedure, and only a limited number of standalone devices are reimbursable.

Moreover, due to the poor healthcare infrastructure in developing countries and limited awareness regarding advanced diagnosis and treatment options, advanced medical equipment is quite low.

Therefore, the complex reimbursement scenarios in the developed and developing countries and the poor healthcare infrastructure in the developing countries have been limiting the region's market growth.

Market Opportunities

Increasing Focus of the Market Players on Partnerships to Expand their Manufacturing Capability in Asia Pacific Countries

Many medical device companies have been focusing on opening new manufacturing capacity in the Asia Pacific region to expand their product accessibility.

• For instance, in June 2025, GE Healthcare and Kalbe, a pharmaceutical company, announced the opening of the first CT-scanner production facility in Indonesia.

Moreover, the market players have also been focusing on enhancing their existing production facilities to manufacture different types of devices to fulfill the demand for medical equipment in the region.

Therefore, the increasing focus of the market players on expanding their manufacturing capabilities in the region is expected to create huge opportunities for market growth.

Market Challenges

Complex and Fragmented Regulatory Scenario Acts as a Challenge for New Product Launches

Approval pathways vary significantly across countries. Navigating differing national standards remains a barrier, contributing to slower market access for new products.

Limitations in Pricing and Reimbursement Act as a Challenge in Market Expansion

Affordability remains a constraint in lower-income markets. High upfront costs, undefined reimbursement policies, and hospital purchasing preferences limit adoption among local manufacturers. 

ASIA PACIFIC MEDICAL DEVICES MARKET TRENDS

Rapid Adoption of Digital Solutions by Key Players to Drive Growth of High-Tech Medical Devices

As part of a rapidly growing region in the medtech sector, medical device manufacturers in the Asia Pacific countries are increasingly adopting digital solutions such as the internet of medical things (IoMT), cloud computing, big data analytics, and others. Governments across the Asia Pacific support the key trend and technological advancement, encouraging players to launch technologically advanced products and devices.

• For instance, in April 2022, AI Medical Service Inc., a Japanese medical device company, announced that it had raised approximately USD 70 million in funding led by SoftBank Vision Fund 2. The company used deep learning technology to develop endoscopic AI. It will use the funds to accelerate the global adoption of endoscopic AI and finance the development of an in-house cloud-based platform.

Other Trends

Increasing Adoption of Digital Technologies in the Region

IoMT, cloud analytics, AI-enabled software, and telehealth tools are gaining momentum across the region. Regulatory bodies and hospital systems in countries such as China, India, Japan, Australia, and Southeast Asia are encouraging technology-enabled solutions.

Increasing Outsourcing of Medical Device Manufacturing

Outsourcing device manufacturing to regional hubs such as India, China, Malaysia, and Vietnam has been growing significantly. This growth is due to the cost efficiencies, skilled labor, and supportive policy initiatives in the region’s countries.

Download Free sample to learn more about this report.

SEGMENTATION ANALYSIS

By Type

Increasing Focus of Market Players on New Product Launches is Responsible for In-vitro Diagnostics Segment’s Dominance

The market is segmented by type into orthopedic devices, cardiovascular devices, diagnostic imaging, in-vitro diagnostics, minimally invasive surgery (MIS), wound management, diabetes care, ophthalmic, dental, nephrology, general surgery, and others.

The in-vitro diagnostics segment dominated the market in 2024. The segment’s growth is attributed to the increasing focus of the medical equipment companies on new IVD product launches.

• For instance, in November 2022, Seegene Inc. received Australia TGA approval for Allplex HPV HR, indicated for detecting cervical cancer among patients.

Moreover, the dental segment is expected to grow at the fastest CAGR during the forecast period. The segment’s growth is attributed to the growing burden of dental disorders and the increasing public awareness of dental health.

To know how our report can help streamline your business, Speak to Analyst

By End User

Growing Burden of Chronic Diseases and Increasing Hospital Admissions are Responsible for Segment’s Dominance

By end user, the market is segmented into hospitals & ASCs, clinics, and others.

The hospitals & ASCs segment dominated the market in 2024. The growing burden of chronic disorders, along with the increasing hospital admissions for diagnosis and treatment, is responsible for the segment’s dominance.

• According to the data published by the Western Australian AIDS Council (WAAC) in 2023, approximately 29,000 people are suffering from HIV in Australia.

The clinics segment is expected to grow at the fastest CAGR during the forecast period due to the diverse portfolio of tests and treatments offered by clinics and clinical laboratories. Adopting advanced instruments has led to a higher proportion of these diagnostic tests being performed in these settings.

Asia Pacific Medical Devices Market Regional Outlook

Based on country/sub-region, the market is studied across China, India, Japan, Australia, and the rest of Asia Pacific.

China

China accounted for the maximum portion of the total Asia Pacific market by generating a market value of USD 40.31 billion in 2024. The increasing prevalence of chronic & infectious diseases in China, coupled with collaborations by key market players to develop and introduce novel diagnostics and treatment devices in the country, are some of the factors driving the growth of the in-vitro diagnostics market in China. This, along with the growing focus of key players on expanding their geographical reach, is mostly to support the growth of the market in the country.

India

Moreover, the market in India is expected to grow at the fastest CAGR during the forecast period. The market growth in the country is attributed to the increasing focus of the market players on expanding production capabilities in the country to fulfill the growing demand for medical devices.

• In May 2025, Nipro Europe Group Companies announced the glass cartridge production for its application in dental and pen at its manufacturing facility located in India. This initiative aimed at fulfilling the demand for glass cartridges in the Asia Pacific region.

Australia and Rest of Asia Pacific

Moreover, the market in Australia and the rest of the Asia Pacific is expected to grow significantly due to the growing burden of chronic diseases and the improvement in the healthcare infrastructure in the emerging countries.

COMPETITIVE LANDSCAPE

KEY INDUSTRY PLAYERS

Increasing Focus of the Market Players on Partnership to Expand Their Product Portfolio

The Asia Pacific market for medical devices consisted of major players such as Nipro Corporation, Shimadzu Corporation, and Shenzhen Mindray Bio-Medical Electronics Co., Ltd. These players have been focusing on partnering with companies to enhance their product offerings for effective regional treatment.

• In June 2025, Samsung Bioepis entered into a development and commercialization partnership with Nipro Europe Group Companies with the aim of expanding the treatment options for multiple conditions, including immunology, in Japan.

Other prominent players, such as Olympus Corporation and Terumo Corporation Pharma, are also leading the market due to their strong distribution network and strategic initiatives. Other major players are NIHON KOHDEN CORPORATION, Lepu Medical Technology, and Medtronic. These companies are focused on strengthening their product portfolio and distribution network through strategic collaboration and partnerships to increase their Asia Pacific medical devices market share.

LIST OF KEY ASIA PACIFIC MEDICAL DEVICES COMPANIES PROFILED

• Nipro Europe Group Companies (Belgium)
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
• Olympus Corporation (Japan)
• Terumo Corporation (Japan)
• NIHON KOHDEN CORPORATION (Japan)
• Lepu Medical Technology (China)
• GE Healthcare (U.S.)
• Hoffmann-La Roche Ltd (Switzerland)
• Medtronic (Ireland)
• Stryker (U.S.)
• Johnson & Johnson Services, Inc. (U.S.)
• Abbott (U.S.)

KEY INDUSTRY DEVELOPMENTS

• February 2025: Olympus Corporation, in partnership with Southern Philippines Medical Center (SPMC), plans to open a state-of-the-art Training Center for Digestive Endoscopy and Minimally Invasive Surgery. With this partnership, the company aims to fulfill the demand for GI endoscopists and minimally invasive surgeons in Singapore.
• September 2024: Stryker announced the launch of the 1788 advanced imaging platform, surgical visualization system in India.
• September 2024: Olympus Corporation announced the launch of a new 4K camera head1, CH-S700-08-LB, for endoscopic urology and gynecology procedures in Japan, Hong Kong, and Singapore.
• February 2023: Shenzhen Mindray Bio-Medical Electronics Co., Ltd. announced the launch of BeneFusion i/u Series Infusion Systems. These smart pumps aimed to reduce medication errors, streamline workflow, and improve cost-effectiveness.
• January 2023: Terumo Corporation announced its collaboration with Siemens Healthineers India. The collaboration aimed to strengthen cardiac care in India.

REPORT COVERAGE

The research report provides qualitative and quantitative insights into the market and a detailed analysis of the Asia Pacific market size and growth rate for all possible market segments. Along with the market forecast, the research report elaborates on the market dynamics and competitive landscape. Various key insights presented in the report are an overview of the number of procedures, price analysis of types of products, regulatory scenario by key countries, pipeline analysis, new product launches, key industry developments (mergers, acquisitions & partnerships), and the impact of COVID-19 pandemic on the market.

To gain extensive insights into the market, Download for Customization

Report Scope & Segmentation